REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $268,915 | -47.8% | 1,901 | -37.9% | 0.11% | -59.7% |
Q1 2023 | $515,182 | +68.9% | 3,060 | +47.8% | 0.28% | +23.6% |
Q3 2020 | $305,000 | +35.0% | 2,070 | -29.7% | 0.22% | +204.1% |
Q3 2019 | $226,000 | +4.1% | 2,943 | -19.9% | 0.07% | -25.3% |
Q1 2019 | $217,000 | -23.9% | 3,672 | -31.9% | 0.10% | -41.8% |
Q4 2018 | $285,000 | – | 5,396 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |